Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
AARD
MXCT
Add up to 3 more stocks
AARD
Aardvark Therapeutics, Inc. Common Stock
-2.87%
$5.07-0.15Delayed quote: Oct 6, 2026, 11:44 AM EDT
Market Cap
$110.95M
52W Range
$3.35 - $17.94
MXCT
MaxCyte, Inc.
-1.39%
$1.06-0.02Delayed quote: Oct 6, 2026, 11:39 AM EDT
Market Cap
$114.08M
52W Range
$0.64 - $1.87
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 1.48 | 0.72 |
| P/S Ratio | N/A | 3.67 |
| P/FCF Ratio | N/A | N/A |
| EV/EBITDA | N/A | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 0.0% | 79.4% |
| Operating Margin | 0.0% | -137.1% |
| Net Margin | 0.0% | -114.8% |
| ROE | -93.4% | -22.4% |
| ROA | -85.8% | -19.3% |
| ROIC | -98.0% | -19.8% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 12.63 | 12.26 |
| Quick Ratio | 12.63 | 11.47 |
| Debt/Equity | 0.01 | 0.11 |
| Interest Coverage | N/A | N/A |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.